[go: up one dir, main page]

AU6016896A - Heterocyclic compounds, their production and use - Google Patents

Heterocyclic compounds, their production and use

Info

Publication number
AU6016896A
AU6016896A AU60168/96A AU6016896A AU6016896A AU 6016896 A AU6016896 A AU 6016896A AU 60168/96 A AU60168/96 A AU 60168/96A AU 6016896 A AU6016896 A AU 6016896A AU 6016896 A AU6016896 A AU 6016896A
Authority
AU
Australia
Prior art keywords
production
heterocyclic compounds
heterocyclic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60168/96A
Inventor
Etsuya Matsutani
Yu Momose
Takashi Sohda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU6016896A publication Critical patent/AU6016896A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44—Two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AU60168/96A 1995-06-16 1996-06-14 Heterocyclic compounds, their production and use Abandoned AU6016896A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP15004895 1995-06-16
JP7-234235 1995-09-12
JP23423595 1995-09-12
JP7-150048 1995-09-12
JP8107989A JPH09136877A (en) 1995-06-16 1996-04-26 Heterocyclic compound, its production and use thereof
JP8-107989 1996-04-26
PCT/JP1996/001643 WO1997000249A1 (en) 1995-06-16 1996-06-14 Heterocyclic compounds, their production and use

Publications (1)

Publication Number Publication Date
AU6016896A true AU6016896A (en) 1997-01-15

Family

ID=27311117

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60168/96A Abandoned AU6016896A (en) 1995-06-16 1996-06-14 Heterocyclic compounds, their production and use

Country Status (3)

Country Link
JP (1) JPH09136877A (en)
AU (1) AU6016896A (en)
WO (1) WO1997000249A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5814647A (en) 1997-03-04 1998-09-29 Board Of Regents, The University Of Texas System Use of troglitazone and related compounds for the treatment of the climacteric symptoms
WO2000018745A1 (en) * 1998-09-30 2000-04-06 Roche Diagnostics Gmbh Oxazolidine derivatives for the treatment and prevention of metabolic bone disorders
CN1164574C (en) 1999-05-24 2004-09-01 三菱制药株式会社 Phenoxypropylamine compounds
JP2003508391A (en) * 1999-08-31 2003-03-04 マキシア・ファーマシューティカルズ・インコーポレイテッド Benzylidene-thiazolidinediones and analogs and their use in treating diabetes
WO2001030771A1 (en) * 1999-10-28 2001-05-03 Kyowa Hakko Kogyo Co., Ltd. Thiazolidinedione derivatives
CN1236719C (en) 2000-12-22 2006-01-18 皇家菲利浦电子有限公司 Apparatus for toasting bread
CA2440184A1 (en) 2001-03-07 2002-09-19 Incyte San Diego, Inc. Heterocyclic derivatives for the treatment of cancer and other proliferative diseases
AU2002254171A2 (en) 2001-03-08 2002-09-24 Incyte San Diego, Inc. RXR activating molecules
JP2003040877A (en) * 2001-07-24 2003-02-13 Sumika Fine Chemicals Co Ltd Method for producing 5-[6-(2-fluorobenzyloxy)-2- naphthyl]methyl-2,4-thiazolidinedione and method for refining the same
AU2002352706A1 (en) 2001-11-15 2003-06-10 Maxia Pharmaceuticals, Inc. N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders, cancer, and other diseases
WO2003059907A1 (en) * 2002-01-17 2003-07-24 Takeda Chemical Industries, Ltd. Nitrogenous heterocyclic compounds, process for preparation of the same and use thereof
US7102000B2 (en) 2002-03-08 2006-09-05 Incyte San Diego Inc. Heterocyclic amide derivatives for the treatment of diabetes and other diseases
US7196108B2 (en) 2002-03-08 2007-03-27 Incyte San Diego Inc. Bicyclic heterocycles for the treatment of diabetes and other diseases
TW200505913A (en) 2003-03-28 2005-02-16 Hoffmann La Roche Novel oxazole derivatives, their manufacture and use as pharmaceutical agents
US7541472B2 (en) 2004-05-24 2009-06-02 Cropsolution, Inc. 3-Aryl-3-hydroxy-2-methylenepropionic acid esters as fungicides
US7709516B2 (en) * 2005-06-17 2010-05-04 Endorecherche, Inc. Helix 12 directed non-steroidal antiandrogens
CN102408337B (en) * 2010-09-20 2014-02-19 四川大学 (E)-3-[4-(alkoxy)phenyl]acrylic acid ester compound, its preparation method and use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
GB8919434D0 (en) * 1989-08-25 1989-10-11 Beecham Group Plc Novel compounds
FR2680512B1 (en) * 1991-08-20 1995-01-20 Adir NOVEL 2,4-THIAZOLIDINEDIONE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
DK0590793T3 (en) * 1992-08-31 2000-01-31 Sankyo Co Oxazolidine derivatives with anti-diabetic and anti-obesity properties, their preparation and their therapeutic use
TW268952B (en) * 1993-02-26 1996-01-21 Takeda Pharm Industry Co Ltd

Also Published As

Publication number Publication date
JPH09136877A (en) 1997-05-27
WO1997000249A1 (en) 1997-01-03

Similar Documents

Publication Publication Date Title
AU4826196A (en) Cyclic compounds, their production and use
AU6514196A (en) Heterocyclic compounds, their preparation and use
AU3660795A (en) Oxazolidinedione derivatives, their production and use
AU7550398A (en) Heterocyclic compounds, their production and use
AU3839895A (en) Heterocyclic compounds, their preparation and use
AU5100396A (en) Novel heterocyclic compounds
AU679887B2 (en) Azole derivatives, their use, production and usage
AU6016896A (en) Heterocyclic compounds, their production and use
AU6514296A (en) Heterocyclic compounds, their preparation and use
AU8885498A (en) Triazine derivatives, their production and use
AU6983494A (en) Indazolesulfonylurea derivative, use thereof, and intermediate for production thereof
AU1504495A (en) Substituted heterocyclic carboxamidoesters, their preparation and their use as pharmaceuticals
AU5271096A (en) Novel heterocyclic compounds
AU4675596A (en) Azole compounds, their production and use
AU2935895A (en) Tricyclic compounds, their production and use
AU668241B2 (en) Condensed heterocyclic compounds, their production and use
AU1081897A (en) Heterocyclic compounds and their use
AU7001396A (en) Triazole compounds, their production and use
AU1211097A (en) Carbapenem compounds, their production and use
AU5468896A (en) Polypeptides, their production and use
AU6999996A (en) Pyrazin-2-one derivatives, their use, and intermediates for their production
AU3650695A (en) New heterocyclic substituted imidazoloquinoxalinones, their preparation and their use
AU4496896A (en) Cephem compounds, their production and use
AU1209497A (en) Oxazole derivatives, their production and use
AU5270896A (en) Novel heterocyclic compounds